BC Environmental and Occupational Health Research Network

The Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant is designed to build future leaders in the pancreatic cancer research community by supporting promising early-career scientists in their postdoctoral positions through the transition to independence. Applicants must have started postdoctoral or clinical research fellowships on or after July 2, 2007 (i.e., must be in the first five years of a fellowship at the start of the grant term). The Pathway to Leadership Grant provides up to five years of support, totaling $600,000.

The AACR Clinical and Translational Cancer Research Fellowships are open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects may be in any area of clinical and/or translational cancer research.

The AACR Gertrude B. Elion Cancer Research Award is open to tenure-track scientists at the level of assistant professor, who completed postdoctoral studies or clinical fellowships no more than four years prior to the start of the grant term. It provides a one-year grant of $50,000 for salary and benefits, supplies, equipment, and limited travel for the grant recipient. Projects may focus on research in cancer etiology, diagnosis, treatment, or prevention (basic, translational, or clinical cancer research).

AACR Basic Cancer Research Fellowships are one-year grants of up to $45,000 to support the salary and benefits of the fellow. A partial amount of funds, up to 25 percent of the total grant, may be designated for direct research expenses. Research projects are restricted to basic cancer research.

The Landon Foundation-AACR INNOVATOR Award for Research in Personalized Cancer Medicine represents a joint effort between the Landon Foundation and the AACR to accelerate progress in the area of personalized medicine by providing support for physician-scientists who conduct meritorious studies that hold promise for near-patient benefit.
Such studies may include:
• Proof-of-concept studies in humans;
• Translational clinical trials that utilize science-based methodologies for patient selection;
• Multidisciplinary research that includes the incorporation of disciplines that are new to cancer research, i.e., the physical sciences, mathematics, etc.;
• Studies that molecularly target pathways; or
• The identification of genes and genetic variations that play a role in cancer treatment responses; or
• Other innovative areas of cancer therapeutics.

International research collaboration can successfully address the global health problem of cancer through access to unique populations and environments, shared resources, specialized expertise, new concepts and perspectives, innovative methodologies, and/or emerging technologies. However, barriers to sustaining these collaborations exist, such as the lack of funding as well as the lack of sharing of knowledge about these important research partnerships.
This Award will support highly meritorious research that is being conducted collaboratively by investigators in different countries around the world. The goals of the program are to:
• Overcome barriers to international collaboration by providing funding for costs traditional grant mechanisms may not support;
• Raise the profile of the importance of collaboration to conquering the cancer problem; and
• Provide the means to facilitate travel and the sharing of knowledge that otherwise may have been difficult to achieve.

Two-year grant of $100,000. Two grants will be awarded this cycle. The Fellowships are open to postdoctoral and clinical research fellows. Applications are invited from researchers currently in the field as well as from investigators with experience in other areas of cancer research who have promising ideas or research approaches that can be applied to ileal carcinoid tumor research. Proposed research may be basic, translational, clinical, or epidemiological in nature and must have direct application and relevance to ileal carcinoid tumors.

The Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Research were established in 2007 to provide support for innovative cancer research projects designed to accelerate the discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent.
It is anticipated that two grants of up to $200,000 each will be awarded.

The AACR Gertrude B. Elion Cancer Research Award is open to tenure-track scientists at the level of Assistant Professor, who completed postdoctoral studies or clinical fellowships no more than five years prior to the start of the grant term. It provides a one-year grant of $50,000 for salary and benefits, supplies, equipment, and limited travel for the grant recipient. Projects may focus on research in cancer etiology, diagnosis, treatment, or prevention (basic, translational, or clinical cancer research).

The INNOVATOR Award for Personalized Cancer Medicine provides a two-year grant of $100,000 ($50,000 per year) for direct research expenses, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, and/or research assistants, research/laboratory supplies, and equipment.

This Award will support highly meritorious research that is being conducted collaboratively by investigators in different countries around the world. The goals of the program are to:
• overcome barriers to international collaboration by providing funding for costs traditional grant mechanisms may not support;
• raise the profile of the importance of collaboration to conquering the cancer problem; and
• provide the means to facilitate travel and the sharing of knowledge that otherwise may have been difficult to achieve.

The AACR‐The ASCO Cancer Foundation Young Investigator Translational Cancer Research Award provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund physician‐scientists during the transition from a fellowship program to a faculty appointment. The Award is open to physicians (M.D., D.O., or international equivalent) or physicians holding a combined M.D./Ph.D. Applicants must be working in an oncology laboratory or clinical research setting in an academic medical institution. Research projects are restricted to translational cancer research. The Award provides a 1‐year grant of $50,000 to support direct research expenses, which may include the salary and benefits of the grant recipient, postdoctoral or clinical research fellows and/or research assistants, research/laboratory supplies, and equipment.

The AACR Judah Folkman Fellowship for Anti‐Angiogenesis Research is open to Postdoctoral and Clinical Research Fellows with a medical degree or a combined M.D./Ph.D. working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects are restricted to basic, clinical, translational or epidemiological projects that substantially advance the field of anti‐angiogenesis research in cancer.
The Fellowship provides a 2‐year grant of $90,000 ($45,000 per year) to support the salary and benefits of the Fellow while working on a mentored anti‐angiogenesis cancer research project. A partial amount of funds, up to 25% of the total grant, may be designated for direct research expenses.

• AACR‐Astellas USA Foundation Fellowship in Clinical/Translational Cancer Research ‐ $30,000 grant
The AACR Clinical and Translational Cancer Research Fellowships are open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects may be in any area of clinical and/or translational cancer research.
The Fellowships provide a 1‐year grant to support the salary and benefits of the Fellow while working on a mentored clinical and/or translational cancer research project. A partial amount of funds, up to 25% of the total grant, may be designated for direct research expenses.

• AACR Anna D. Barker Fellowship in Basic Cancer Research ‐ $40,000 grant
• AACR‐Astellas USA Foundation Fellowships in Basic Cancer Research ‐ $30,000 grant
The AACR Basic Cancer Research Fellowships are open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the 1st, 2nd, or 3rd year of their postdoctoral training at the start of the grant term. Proposed research projects may be in any area of basic cancer research.
The Fellowships provide a 1‐year grant to support the salary and benefits of the Fellow while working on a mentored basic cancer research project. A partial amount of funds, up to 25% of the total grant, may be designated for direct research expenses.
It is anticipated that one AACR Anna D. Barker and two AACR‐Astellas USA Foundation Fellowships will be funded.

The AACR‐AstraZeneca Fellowship for Translational Lung Cancer Research is open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects must relate directly to translational lung cancer research.
The Fellowship provides a 2‐year grant of $90,000 ($45,000 per year) to support the salary and benefits of the Fellow while working on a mentored translational lung cancer research project. A partial amount of funds, up to 25% of the total grant, may be designated for direct research expenses.

This is a one-year grant of $35,000. Research projects are restricted to translational pancreatic cancer research that includes the use of human tissue and has implications for therapeutic application and individualized medicine. Proposed research must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not. One grant will be awarded this cycle.

is a one-year grant of $30,000. Research projects are restricted to translational or clinical cancer research that has an ultimate goal of developing or improving therapeutic interventions for patients with metastatic colorectal cancer. One grant will be awarded this cycle.

AACR Career Development Awards are open to junior faculty at an academic, medical, or research institution who completed postdoctoral studies or clinical fellowships no more than three years prior to the start of the grant term.
The Awards provide two-year grants of $50,000 per year for direct research expenses and salary support.

AACR Postdoctoral Fellowships are open to Postdoctoral Fellows and Clinical Research Fellows who are working at an academic facility, teaching hospital, or research institution and who will be in the first, second, or third year of their postdoctoral training at the start of the fellowship term.
Fellowships support the salary and benefits of the Fellow, with partial funds (up to 25% of the total grant) permitted to be designated to direct research expenses.